Biotechnology ETF Short
The NASDAQ Biotechnology Index is a modified capitalization weighted index that includes securities of The NASDAQ Stock Market listed companies that are classified as either biotechnology or pharmaceutical. The securities also meet other eligibility criteria determined by The NASDAQ OMX Group, Inc., including minimum market capitalization and liquidity requirements.
|Total Number of Companies||150|
|Average Index Market Capitalization||$6.64 billion|
* Derivative contracts are priced to reflect the underlying index yield and will not generate dividend income. Because ProShares invest in derivatives, they will not have dividend distributions that reflect those of their applicable indexes.
|Top 10 Index Companies ‡||Weight|
|Biogen Idec Inc.||8.11%|
|Gilead Sciences Inc.||7.45%|
|Regeneron Pharmaceuticals Inc.||6.54%|
|Vertex Pharmaceuticals Inc.||3.88%|
|Alexion Pharmaceuticals Inc.||3.78%|
|BioMarin Pharmaceutical Inc.||2.95%|
‡ ProShares may invest in financial instruments (including derivatives) that, in combination, should have similar daily price return characteristics to the fund's benchmark.
|Index Sector Weightings §|
Patenting Proteomics: Patentability and Scope of Protection of Three-Dimensional Protein Structure Claims under German, European and US Law (Munich Intellectual Property Law Center - MIPLC)
Book (Nomos Publishers)